Most of the genetic models showed no significant association between the combined effects of GSTs (GSTM1, GSTT1 and GSTP1) polymorphisms and RCC risk, except for the two dual null genotypes of GSTM1-GSTT1 and GSTT1-GSTP1. This evidence concerns the gene GSTM1 and renal cell adenocarcinoma.